Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 1,921,800 | 2,095,400 | 1,806,100 | 2,215,400 | 2,145,300 |
| Cost of Goods | 1,129,000 | 1,228,400 | 1,072,800 | 1,327,000 | 1,255,000 |
| Gross Profit | 792,800 | 867,000 | 733,300 | 888,400 | 890,300 |
| Operating Expenses | 538,000 | 883,400 | 506,900 | 552,200 | 522,300 |
| Operating Income | 254,800 | -16,000 | 227,200 | 336,200 | 368,000 |
| Interest Expense | 60,400 | 58,200 | 60,600 | 67,500 | 74,200 |
| Other Income | 285,100 | -13,700 | -400 | 8,100 | 12,500 |
| Pre-tax Income | 479,500 | -87,900 | 166,200 | 276,800 | 306,300 |
| Income Tax | 171,400 | -38,400 | 52,400 | 79,900 | 92,100 |
| Net Income Continuous | 308,100 | -49,500 | 113,800 | 215,100 | 208,000 |
| Net Income Discontinuous | 30,200 | 109,400 | 12,900 | 10,800 | 900 |
| Minority Interests | 2,400 | -76,100 | 6,200 | N/A | N/A |
| Net Income | $335,900 | $136,000 | $120,500 | $201,500 | $208,900 |
| EPS Basic Total Ops | 2.24 | 0.89 | 0.78 | 1.31 | 1.36 |
| EPS Basic Continuous Ops | 2.04 | 0.17 | 0.70 | 1.23 | 1.36 |
| EPS Basic Discontinuous Ops | 0.20 | 0.72 | 0.08 | 0.07 | 0.01 |
| EPS Diluted Total Ops | 2.21 | 0.88 | 0.77 | 1.29 | 1.33 |
| EPS Diluted Continuous Ops | 2.01 | 0.17 | 0.69 | 1.21 | 1.33 |
| EPS Diluted Discontinuous Ops | 0.20 | 0.71 | 0.08 | 0.07 | 0.01 |
| EBITDA(a) | $322,500 | $50,800 | $291,800 | $412,800 | $435,400 |